Most AI in healthcare doesn’t fail in production. It fails right after the demo is over.

A team builds something useful with perceived real ROI. A model that flags rising-risk patients or a tool that takes a day out of prior auth. It works. High fives all around. Then someone from compliance asks a few questions. What was the source of this data? Who’s allowed to see it? Could you explain this output to an auditor if you had to?

Nobody knows any of the answers.

What happens next is usually one of two things. The project stalls for a couple of quarters while teams retrofit controls, or it ships with governance bolted on afterward and a quiet hope that nobody digs too deep or asks too many questions.

Governance as a compliance check point not as a product foundation is the core problem. Not because the people doing it are careless. They’re usually the most cautious ones. It’s that by the time you’re adding controls to a system that already runs, you’ve lost most of the leverage you had at the start. Your AI has already found the exit door.

Retrofitted governance doesn’t hold. You’re writing access rules around data you already copied into four systems. You’re documenting the lineage of a model that trained on a snapshot nobody kept notes on. None of it survives a regulator, a payer auditing your risk scores, or an attorney with unlimited time.

The fix isn’t more paperwork. It’s a different starting assumption: Governance lives in the data fabric, not in a layer you apply to the outputs at the end.

Usually, Healthcare Identity comes first. Match patients badly and your AI is confident about the wrong human. No model tuning fixes that.

Product teams should obsess about lineage captured as the data moves, not rebuilt later. When a care manager asks why a patient surfaced on her list, the trail should run back through the model to the FHIR resources and claims underneath it. Access control at the data layer, not per app. Govern the data once and every tool inherits it. It’s a massive multiplier and solid compliance gate.

This matters most where the money and the exposure pile up. A model that lifts RAF accuracy is worth a lot, right up to the moment you can’t show your work. Then it’s a lot of audit risk with nice dashboards. Quality measurement is the same. The modeling is the easy part now. Governance decides whether you can actually use what the model gives you.

I understand why it slides to the bottom of the list. Governance doesn’t demo well. Nobody claps at a lineage diagram. It takes time to plan it out. The AI use case is usually very exciting.

But the organizations that build it in move faster, for a reason that’s almost self-fulfilling. They never hit the wall, compliance reviews become repetitive. When the audit comes, or the board asks the hard question, the answer is already there, because the system was built to produce it.

The teams that treat governance as a tax keep paying it in delay and rework. The ones that treat it as architecture pull a little further ahead every cycle.

Build it early or plan on building everything twice.

In my work with CareInMotion, quality data is non-negotiable, providing a solid, trustworthy foundation for smarter care decisions. Learn more here.